| |
|
|
|
|
|
|
|||
|
Blood, 15 October 2006, Vol. 108, No. 8, pp. 2506-2507.
VEGF calls its receptors from the recycling compartmentKAROLINSKA INSTITUTET
VEGF stimulates neovascularization via activation of its key receptor VEGFR-2 signaling pathway in endothelial cells. In this issue of Blood, Gampel and colleagues report that a significant proportion of VEGFR-2 molecules are stored in an endosomal recycling compartment and that VEGF mobilizes these intracellular receptors to the cell surface, which might increase the sensitivity of endothelial cells to proangiogenic signals.
The initial surprising notion of the study by Gampel and colleagues is that 3 independent anti-VEGFR-2 antibodies give rise to a punctuated staining pattern rather than staining of the receptor at the cell surface in 2 endothelial cell lines. To reveal the identity of these intracellular VEGFR-2-positive structures, EEA1 (an early endosome-associated protein) and Rab4 (a marker of the "short-loop" recycling pathway) are colocalized with VEGFR-2+ vesicles. A significant number of VEGFR-2 molecules are also colocalized with CD63 (a marker for late endosomes). Quantification analysis demonstrates that roughly 40% of VEGFR-2 is stored in the endosomal compartment in endothelial cells (see figure). Previous studies with other tyrosine kinase receptors (TKRs), including epidermal growth factor receptors (EGFRs) and platelet-derived growth factor receptors (PDGFRs), have demonstrated that upon ligand stimulation these receptors are down-regulated by endocytosis, followed by lyosomal degradation to down-regulate the persistent signaling.6,7 In contrast to these TKRs, stimulation of VEGFR-2 with VEGF does not lead to loss of the total intracellular pool of VEGFR-2, albeit redistribution of VEGFR-2 from the early endosomal compartments into the late endosomes. Intriguingly, most VEGFR-2 molecules are stored in the late endosomes without further degradation. One of the most important findings of this study is that stimulation of endothelial cells with VEGF leads to accumulation of VEGFR-2+ vesicles beneath the plasma membrane, particularly in the protrusion area. Using a novel biotinylation method, Gampel and colleagues have quantified the recycling event of VEGFR-2 and found that VEGF stimulation can dramatically increase the recycling of the intracellular VEGFR-2 to the cell surface. This finding is very surprising since VEGFR-2 is thought to be destroyed after signaling to desensitize the ligand. The increase of recycling of TKRs upon ligand stimulation seems to be a unique feature for the VEGFR-2 trafficking. Even more surprisingly, the intracellular recycling VEGFR-2+ vesicles also contain Src, which plays a crucial role in mediating VEGF-induced vascular permeability and endothelial motility. These findings suggest that Src as a downstream signaling component is also assembled in the same type of vesicles and is ready for signaling. Targeted recycling of VEGFR-2 might help us to understand the essential process of vascular sprouting and branch formation. Accumulation of VEGFR-2 molecules in a particular region of the endothelial cell plasma membrane might lead to formation of the protrusive filopodia at the sprout tip and guide movement of endothelial cells toward the VEGF gradient. This directed movement of endothelial cells is essential for vascular sprouting, branching, permeability, and the formation of a functional network.
Understanding of intracellular trafficking events of VEGFR-2 might help us to define novel therapeutic targets for intervention of the VEGF/VEGFR-2 signaling system. The present study has paved a new avenue for approaching this goal. However, at present there are several unanswered questions. Are the recycled VEGFR-2 molecules functional? Does VEGF-C, another ligand for VEGFR-2, also increase recycling of intracellular VEGFR-2 to the cell surface? What about VEGFR-1 and VEGFR-3? These are several important issues that warrant future studies. References
Related Article in Blood Online:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2006 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||